GCP ClinPlus Named “Best Enabling Service Organization”

We’re honored to share that GCP ClinPlus was recognized at the 10th Annual Forum of the New Drug Founders Conference in Shanghai as a “Best Enabling Service Organization.”

This prestigious award, selected by senior industry experts, celebrates service providers making outstanding contributions to China’s biopharma innovation ecosystem.

With over 22 years of clinical trial expertise, 2,200+ studies supported, and 210+ product approvals, GCP ClinPlus stands out as one of China’s earliest and most experienced international CROs. Our portfolio includes several large-scale trials with over 20,000 participants.

• Digitally Driven Operations

Our proprietary data integration platform provides real-time, dynamic trial management—enhancing data integrity and oversight efficiency.

• Pioneering in Cell & Gene Therapy

We’re strategically expanding in this frontier space, building on our robust foundation to support global biotech in cell and gene therapy trials across China.

As China’s innovative therapies reach the global stage, GCP ClinPlus remains committed to being your trusted clinical partner in Asia.

Let’s unlock your pipeline potential—together.